Dr. Jung Ho Choi investigates how informational frictions and innovations have an influence on the processes and outcomes of the labor market and how these factors interact with each other. Using corporate disclosure as a major research setting, he studies how informational frictions, especially about employers, can interact with the labor market in three different dimensions:

Dr. Carolyn Rodriguez is Associate Dean for Academic Affairs, Stanford University School of Medicine, Associate Chair for Inclusion and Diversity in the Department of Psychiatry and Behavioral Sciences at Stanford University, and a Consultation-Liaison Psychiatrist at the Palo Alto Veterans Affairs. As the Director of the Translational Therapeutics Lab and Professor in the Department of Psychiatry and Behavioral Sciences, Dr. Rodriguez leads studies investigating the brain basis of severe mental disorders.

Dr. Todd P. Coleman is an Associate Professor in the Department of Bioengineering, and by courtesy, Electrical Engineering at Stanford University. He received B.S. degrees in electrical engineering (summa cum laude), as well as computer engineering (summa cum laude) from the University of Michigan. He received M.S. and Ph.D. degrees from MIT in electrical engineering and computer science. He did postdoctoral studies at MIT and Mass General Hospital in quantitative neuroscience.

Dr. Michael Rosen is a pediatric gastroenterologist and physician scientist, who has been devoted to inflammatory bowel disease (IBD) research since beginning medical training over 20 years ago. He is also Director of the Stanford Center for Pediatric IBD and Celiac Disease. Dr. Rosen has expertise crossing mucosal immunology and epithelial biology, formal training and experience in clinical and translational investigation with human biospecimens, and direct insight regarding the important clinical challenges caring for children with complicated IBD.

Dr. Nathanael Gray's Laboratory develops first-in-class chemical probes that are used to gain new biological insights into cellular processes that drive cancer and other diseases, and to pharmacologically validate potential clinically relevant targets. They take an integrative approach that combines medicinal chemistry, structural biology, biochemistry and molecular and cell biology to develop new therapeutic strategies. Their work has contributed to several approved and clinical stage drugs targeting BCR-ABL, Sphingosine-1-phosphate receptor (S1PR), EGFR, EML4-ALK and CDK7.

Dr. Steven Banik's research interests center on rewiring mammalian biology and chemical biotechnology development using molecular design and construction. Projects in the Banik lab combine chemical biology, organic chemistry, protein engineering, cell and molecular biology to precisely manipulate the biological machines present in mammalian cells.

Dr. Maya Kasowski is a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. She completed her MD-PhD training at Yale University and her residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. Dr. Kasowski's experiences as a clinical pathologist and genome scientist have made her passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level.

Dr. Christopher Barnes's lab is at the intersection of medicine, basic science and engineering. Viruses are inextricably linked to the host cells that they infect. Thus, investigating viral-host interactions is essential to understand the mechanisms of viral entry, replication, pathogenesis, and the host’s ability to respond to viral pathogens. The Barnes lab excels in leveraging interdisciplinary approaches to address fundamental principles of viral-host interactions for therapeutic benefit.

Dr. Julia Noel completed her undergraduate work in Biochemistry/Cell Biology and Economics at the University of California in San Diego. She remained at UCSD for medical school, then relocated to Stanford University, where she completed her residency in Otolaryngology Head & Neck Surgery. She then pursued a fellowship in Endocrine Head & Neck Surgery at Stanford.

Dr. Wendy Liu, MD, PhD, is a fellowship-trained glaucoma and cataract surgeon. Her clinical practice focuses on management of adult glaucoma and cataracts. She specializes in traditional glaucoma surgery as well as minimally-invasive glaucoma surgery, such as iStent, Hydrus, Xen, KDB, OMNI, and GATT. Her goal is to work together with patients to determine what the best treatment options are for them, so they can maintain the best vision and quality of life.